Shashank Deshpande | Boehringer Ingelheim FI

Shashank Deshpande

Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit

Credentials

• Diplom-Kaufmann (Masters’ degree in Business Administration), University of Hamburg, Hamburg, Germany

Professional milestones

• 2025 - Present
  Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit

• 2024 - Present
  Member of the Board of Managing Directors with responsibility for the Human Pharma Business Unit

• 2024 - 2024
  Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit

• 2022 - 2023
  Country Managing Director, Japan

• 2020 - 2022
  Head of Human Pharma, Japan

• 2019 - 2020
  Head of Specialty Care, Japan

• 2017 - 2019
  Head of Marketing, Japan

• 2014 - 2017
  Head of Diabetes Marketing, Japan

• 2012 - 2014
  Global Brand Team Leader Trajenta® (Ingelheim, Germany)

• 2002 - 2012
  Various roles in US and Global Marketing at Sanofi, US

• 1999 - 2002
  Strategy consultant at Cap Gemini, Germany

[Michael Schmelmer](/content/fi/tietoa-meista/keita-olemme/yritysjohto/michael-schmelmer "Read more about "Michael Schmelmer""/index.html)

[Dr Paola Casarosa](/content/fi/tietoa-meista/keita-olemme/yritysjohto/dr-paola-casarosa "Read more about "Dr Paola Casarosa""/index.html)

[Harsha Deshmukh](/content/fi/tietoa-meista/keita-olemme/yritysjohto/harsha-deshmukh "Read more about "Harsha Deshmukh""/index.html)

[Frank Hübler](/content/fi/tietoa-meista/keita-olemme/yritysjohto/frank-hubler "Read more about "Frank Hübler""/index.html)

[Dr Armin Wiesler](/content/fi/tietoa-meista/keita-olemme/yritysjohto/dr-armin-wiesler "Read more about "Dr Armin Wiesler""/index.html)

References